Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.

Raha-Chowdhury R, Henderson JW, Raha AAlexander, Stott SRW, Vuono R, Foscarin S, Wilson L, Annus T, Fincham R, Allinson K, et al.
J Alzheimers Dis. 2018; 61(3):1143-1162. PMID: 29278889. Abstract